v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 1,330,000
Prepaid expenses 203,000 8,000
Due from Sponsor 65,000
Deferred offering costs 83,000
Total current assets 1,598,000 91,000
Investments held in trust account 202,715,000
Total Assets 204,313,000 91,000
Current liabilities    
Accounts payable 1,000 30,000
Accrued liabilities (including approximately $75,000 and $83,000, respectively, of offering costs at June 30, 2026 and December 31, 2025) 279,000 83,000
Deferred compensation 113,000
Total current liabilities 393,000 113,000
Deferred underwriting payable 7,044,000
Total liabilities 7,437,000 113,000
Commitments and Contingencies (Note 7)
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at June 30, 2026 or December 31, 2025
Additional paid-in capital 24,000
Accumulated deficit (5,590,000) (47,000)
Total Shareholders’ Deficit (5,589,000) (22,000)
Total Liabilities and Shareholders’ Deficit 204,313,000 91,000
Class A Ordinary Shares    
Current assets    
Investments held in trust account 250,000  
Current liabilities    
Class A ordinary shares subject to possible redemption, 20,125,000 and 0 shares, respectively, at June 30, 2026 and December 31, 2025, at redemption value of $10.06 per share at June 30, 2026 202,465,000
Shareholders’ Deficit    
Ordinary shares, value
Class B Ordinary Shares    
Shareholders’ Deficit    
Ordinary shares, value [1] $ 1,000 $ 1,000
[1] Includes, at December 31, 2025, up to 875,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option had not been exercised in full by the underwriters on the closing of the Public Offering on April 16, 2026 (see Note 5).